SurgeryNCT06619730
Brain Function Monitoring During Surgery
A study testing Sedline Brain Function Monitor in people with Surgery, run by University of Chicago at 1 site in United States.
Trial summary
The purpose of this research is to gather information on the effectiveness of the Sedline Brain Function Monitor, and its use in this study to determine whether monitoring the brain activity during anesthesia will improve recovery, including earlier discharge and less side effects. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Surgery
- What is being tested?
- Sedline Brain Function Monitor
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Aug 2024to 14 Nov 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- American Society of Anesthesiology Physical Status Classification Grade of 1(normal, healthy patient) to Grade 3 (patient with severe disease)
- Between ages 18-45 years old
- Planned surgery duration between 60-240 minutes General-endotracheal-tube-anesthesia or general anesthesia with laryngeal mask airway
- Subjects capable of giving informed consent or
- Subjects who have an acceptable surrogate capable of giving consent on behalf of the subject
- All contraception methods will be allowable for any subject in this study. Participants may opt-out of a pregnancy test if they would prefer to proceed with surgery without one.
- Pregnant women will not be strictly excluded from this study if they meet all other criteria.
Who cannot join
- American Society of Anesthesiology Physical Status Classification Grade of 4,5,6 (diseases that are life threatening or no possibility of survival)
- Listed allergies to any commonly used anesthetic agents
- History of seizures, as a seizure while using brain monitoring may influence the anesthesia provider in a way that is not aligned with the purpose of this study
- Any patient undergoing emergency surgery, as can not be ensured that consent will be able to be properly obtained
- Patient refusal to participate in study
- Any patient undergoing surgery that would prevent placement of the Sedline monitor leads (for example - surgery on the patient's forehead/scalp)
Show all 9Show fewer
- Patients who receive neuraxial anesthesia or a peripheral nerve block as part of their anesthetic
- Patients who are taking gender-affirming hormonal medications, as this can affect the response to anesthetics
- The duration of surgery scheduled <60 minutes
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Chicago Medical Center
Chicago, Illinois, 60637
About this study
Official title: Using Brain Function Monitors to Guide Anesthetic Management in Improving Anesthesia Recovery: a Randomized Pilot Study to Compare Outcomes in Young Adult Patients.
The purpose of this research is to gather information on the effectiveness of the Sedline Brain Function Monitor, and its use in this study to determine whether monitoring the brain activity during anesthesia will improve recovery, including earlier discharge and less side effects. Furthermore, the study team wants to determine whether males and females respond to anesthetics in a similar manner with and without brain monitoring.
Read the detailed description
While brain function monitoring has been shown to help guide optimal anesthetic dosing and improve recovery in the elderly and young children, its benefits in young adults are not well defined. We hypothesize that brain monitor-guided anesthetic management would decrease post-anesthesia recovery time and improve postoperative experience in this younger group.
This prospective, randomized, single-blinded study at the University of Chicago Medical Center, will enroll adult approximately 100 evaluable patients aged 18-45 years, with ASA physical status I-III, undergoing a scheduled elective surgery, with an anticipated 60-240 minute duration, and receiving general anesthesia. Exclusion criteria includes ASA IV-VI, allergy to anesthetic agents, history of seizures, emergency surgery, procedures precluding SedLine electrode placement, use of gender affirming hormonal therapy, and refusal to participate.
Participants are randomized using gender-stratified block randomization with variable block sizes (4 and 6) generated by an independent biostatistician. Participants and PACU nurses are blinded to group allocation. The anesthesia providers are not blinded due to the nature of the intervention. Postoperative survey interviewers are not blinded.
A member of the research team will use the surgery schedule to identify patients meeting initial study screening criteria. Patients identified as meeting criteria will be approached and study details will be discussed, and after being given time to ask questions, informed consent will be obtained.
The anesthesa care team (i.e., anesthesia providers, etc.) will receive instructions regarding interventional-arms anesthesia administration (i.e., chemical, gas, monitoring, etc.) to use in association with standard of care.
Brain monitoring group: Sedline Density Spectral Array (DSA) between 8-15 or/and Patient State Index (PSI) reading between 25-50 throughout the course of the case in the subjects who are randomly selected in the monitoring group. If the blood pressure (BP) or heart rate (HR) is over 25-30 % baseline, an opioid or other pain medications will be used first, before increasing the dose of inhalational agent or propofol. If BP is low and PSI is on the low end, study team will lower the inhalational agent or propofol first. If the patient moves and BP and PSI are within the ranges, muscle relaxant may be given first unless the use of muscle relaxant is not allowed for the surgical reason. If both opioids and muscle relaxant adjustment fail to achieve the hemodynamic stability and immobility goal, then the study team will adjust the doses of inhalational agent or propofol.
General anesthesia is projected to last 60-240 minutes. The anesthesia care team will treat each sedation component of general anesthesia (i.e., unconsciousness, immobility, nociception and hemodynamic stability) accordingly while the study team understands the 4 components are interlinked.
Non-monitoring group (control or conventional group), the anesthesia providers will administer the anesthetics in the conventional manner, mainly based on the hemodynamic responses and the minimum alveolar concentration (MAC) of inhalational agents during the surgery. The brain activities are not usually monitored in real time by a brain monitor. The anesthesia providers are allowed to use inhalational, intravenous anesthetic agents, opioids and muscle relaxants to produce adequate general anesthesia in both groups. Overall anesthesia care during the surgery will not be compromised.
The anesthesia provider will apply a Sedline Monitor to their forehead during the general anesthesia procedure. The anesthesia provider may use the data from the monitor to affect their anesthetic administration, or may cover the data from the monitor and only use conventional measures to guide anesthetic dosing in these control cases (blood pressure, heart rate, body movement, respiratory rate, MAC of inhalational agent), depending on what group into which the patient has been randomized.
The research team will monitor patient surgical recovery and length of stay (i.e., minutes) in post-operative acute care unit (PACU). The use of validated diagnostic (numeric rating scale (NRS)) to assess post-operative recovery symptoms (i.e., pain, nausea and vomiting) and patient satisfaction with anesthesia received.
Further recovery progress will be assessed at postoperative day-1 (POD1); patients contacted by phone will again rate their satisfaction, pain, nausea and vomiting with the NRS.
- Conditions
- Surgery
- Being tested
- Sedline Brain Function Monitor
- Keywords
- Brain function Monitoring
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sedline Brain Function MonitorDevice
The anesthesia provider will use the Sedline Brain Function Monitor information to affect their anesthetic dosing.
| Study group | Role | What they receive |
|---|---|---|
| Control Arm | No intervention | Conventional method: Anesthesia will not be guided by the Sedline brain function monitor during the procedure. |
| Sedline Monitor Arm | Active comparator | Anesthesia care guided by Sedline brain function monitor during the procedure. Receives: Device: Sedline Brain Function Monitor |
What is being measured
The primary outcome is the main question the study is designed to answer.
Speed of Recovery Time
The primary endpoint is the speed of recovery time, measured from the end time of the surgery, to the time of meeting the criteria for pediatric acute care unit (PACU) discharge. These criteria are lack of nausea/vomiting, grogginess and the level of pain; with 0 being no pain and 10 being severe pain.
Measured: Up to 3 hours
Secondary outcomes (2)
Patient Rated - PostOperative Pain and Anesthesia Experience
Patient pain level rated postoperatively in recovery and satisfaction with anesthesia experience rated, using validated diagnostics:
Numeric Pain Rating Scale (NPRS) Measures patient-reported pain intensity. Score range: 0 to 10 (0 = no pain, 10 = worst imaginable pain) Directionality: Higher scores indicate worse pain.
5-Point Likert Satisfaction Scale Measures overall satisfaction with the anesthetic experience. Score range: 1 to 5 (1 = very dissatisfied, 5 = very satisfied) Directionality: Higher scores indicate better satisfaction.
Measured: Up to 1 day post surgery
Gender-Stratified, PostOperative Care Unit (PACU) Discharge Length of Stay Rate (Minutes) Between Sedline Brain Monitoring-Arm vs Control-Arm
Evaluate the PostOperative Care Unit (PACU) discharge length of stay rates (minutes) between randomized study-arms are gender-stratified.
Calculated PACU discharge rates will be gender-stratified between study arms. Determining factors for discharge readiness included, electroencephalogram (EEG) interpretation, post-anesthesia recovery and return to baseline, and symptom severity (i.e., nausea, agitation, etc.)
Brain Monitoring Arm - Male Control Arm - Male
Brain Monitoring Arm - Female Control Arm - Female
Measured: Up to 2 days post surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Oct 2024
- Study start6 Aug 2024
- Primary completion14 Nov 2024
- Study completion14 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for SurgeryStudies of the same condition, open and under way.
- More trials run by University of ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Zheng Xie, MD, PhD, Principal investigator, University of Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06619730
- Sponsor's protocol ID
- IRB24-0454
- Status last verified
- Jul 2026
- First submitted
- 7 Aug 2024
- Last updated
- 12 Aug 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using Brain Function Monitors to Guide Anesthetic Management in Improving Anesthesia Recovery: a Randomized Pilot Study to Compare Outcomes in Young Adult Patients.
- ClinicalTrials.gov ID
- NCT06619730
- Acronym / sponsor ID
- IRB24-0454
- Conditions
- Surgery
- Keywords
- Brain function Monitoring
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- University of ChicagoUniversity, hospital or other
- Study start
- 6 Aug 2024 (actual)
- Primary completion
- 14 Nov 2024 (actual)
- Study completion
- 14 Nov 2024 (actual)
- First posted
- 1 Oct 2024 (actual)
- Results
- Posted 12 Aug 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research is to gather information on the effectiveness of the Sedline Brain Function Monitor, and its use in this study to determine whether monitoring the brain activity during anesthesia will improve recovery, including earlier discharge and less side effects. Furthermore, the study team wants to determine whether males and females respond to anesthetics in a similar manner with and without brain monitoring.
Detailed description
While brain function monitoring has been shown to help guide optimal anesthetic dosing and improve recovery in the elderly and young children, its benefits in young adults are not well defined. We hypothesize that brain monitor-guided anesthetic management would decrease post-anesthesia recovery time and improve postoperative experience in this younger group.
This prospective, randomized, single-blinded study at the University of Chicago Medical Center, will enroll adult approximately 100 evaluable patients aged 18-45 years, with ASA physical status I-III, undergoing a scheduled elective surgery, with an anticipated 60-240 minute duration, and receiving general anesthesia. Exclusion criteria includes ASA IV-VI, allergy to anesthetic agents, history of seizures, emergency surgery, procedures precluding SedLine electrode placement, use of gender affirming hormonal therapy, and refusal to participate.
Participants are randomized using gender-stratified block randomization with variable block sizes (4 and 6) generated by an independent biostatistician. Participants and PACU nurses are blinded to group allocation. The anesthesia providers are not blinded due to the nature of the intervention. Postoperative survey interviewers are not blinded.
A member of the research team will use the surgery schedule to identify patients meeting initial study screening criteria. Patients identified as meeting criteria will be approached and study details will be discussed, and after being given time to ask questions, informed consent will be obtained.
The anesthesa care team (i.e., anesthesia providers, etc.) will receive instructions regarding interventional-arms anesthesia administration (i.e., chemical, gas, monitoring, etc.) to use in association with standard of care.
Brain monitoring group: Sedline Density Spectral Array (DSA) between 8-15 or/and Patient State Index (PSI) reading between 25-50 throughout the course of the case in the subjects who are randomly selected in the monitoring group. If the blood pressure (BP) or heart rate (HR) is over 25-30 % baseline, an opioid or other pain medications will be used first, before increasing the dose of inhalational agent or propofol. If BP is low and PSI is on the low end, study team will lower the inhalational agent or propofol first. If the patient moves and BP and PSI are within the ranges, muscle relaxant may be given first unless the use of muscle relaxant is not allowed for the surgical reason. If both opioids and muscle relaxant adjustment fail to achieve the hemodynamic stability and immobility goal, then the study team will adjust the doses of inhalational agent or propofol.
General anesthesia is projected to last 60-240 minutes. The anesthesia care team will treat each sedation component of general anesthesia (i.e., unconsciousness, immobility, nociception and hemodynamic stability) accordingly while the study team understands the 4 components are interlinked.
Non-monitoring group (control or conventional group), the anesthesia providers will administer the anesthetics in the conventional manner, mainly based on the hemodynamic responses and the minimum alveolar concentration (MAC) of inhalational agents during the surgery. The brain activities are not usually monitored in real time by a brain monitor. The anesthesia providers are allowed to use inhalational, intravenous anesthetic agents, opioids and muscle relaxants to produce adequate general anesthesia in both groups. Overall anesthesia care during the surgery will not be compromised.
The anesthesia provider will apply a Sedline Monitor to their forehead during the general anesthesia procedure. The anesthesia provider may use the data from the monitor to affect their anesthetic administration, or may cover the data from the monitor and only use conventional measures to guide anesthetic dosing in these control cases (blood pressure, heart rate, body movement, respiratory rate, MAC of inhalational agent), depending on what group into which the patient has been randomized.
The research team will monitor patient surgical recovery and length of stay (i.e., minutes) in post-operative acute care unit (PACU). The use of validated diagnostic (numeric rating scale (NRS)) to assess post-operative recovery symptoms (i.e., pain, nausea and vomiting) and patient satisfaction with anesthesia received.
Further recovery progress will be assessed at postoperative day-1 (POD1); patients contacted by phone will again rate their satisfaction, pain, nausea and vomiting with the NRS.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control Arm | No intervention | –Conventional method: Anesthesia will not be guided by the Sedline brain function monitor during the procedure. |
| Sedline Monitor Arm | Active comparator | Device: Sedline Brain Function MonitorAnesthesia care guided by Sedline brain function monitor during the procedure. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- American Society of Anesthesiology Physical Status Classification Grade of 1(normal, healthy patient) to Grade 3 (patient with severe disease)
- Between ages 18-45 years old
- Planned surgery duration between 60-240 minutes General-endotracheal-tube-anesthesia or general anesthesia with laryngeal mask airway
- Subjects capable of giving informed consent or
- Subjects who have an acceptable surrogate capable of giving consent on behalf of the subject
Key exclusion criteria (9 listed)
- American Society of Anesthesiology Physical Status Classification Grade of 4,5,6 (diseases that are life threatening or no possibility of survival)
- Listed allergies to any commonly used anesthetic agents
- History of seizures, as a seizure while using brain monitoring may influence the anesthesia provider in a way that is not aligned with the purpose of this study
- Any patient undergoing emergency surgery, as can not be ensured that consent will be able to be properly obtained
- Patient refusal to participate in study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sedline Brain Function MonitorThe anesthesia provider will use the Sedline Brain Function Monitor information to affect their anesthetic dosing. | Device | Sedline Monitor Arm |
Primary outcome
Speed of Recovery Time
Time frame: Up to 3 hours
The primary endpoint is the speed of recovery time, measured from the end time of the surgery, to the time of meeting the criteria for pediatric acute care unit (PACU) discharge. These criteria are lack of nausea/vomiting, grogginess and the level of pain; with 0 being no pain and 10 being severe pain.
2 secondary outcomes
Patient Rated - PostOperative Pain and Anesthesia Experience
Time frame: Up to 1 day post surgery
Gender-Stratified, PostOperative Care Unit (PACU) Discharge Length of Stay Rate (Minutes) Between Sedline Brain Monitoring-Arm vs Control-Arm
Time frame: Up to 2 days post surgery
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Surgery
Not yet recruiting
The Contribution of Accelerated Recovery (mERAS) Approach to Postoperative Recovery in Pediatric Laparoscopic Surgery Cases
mERAS Intervention, The ASA (American Society of Anesthesiologists) Score
RecruitingObservational study
Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
Lung Cancer
RecruitingPhase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Not yet recruiting
The Effect of Compound Chamomile and Lidocaine Hydronchloride Gel as an Endotracheal Tube Lubricant on Postoperative Pharyngeal and Laryngeal Complications in Thoracic Surgery Patients
Postoperative Sore Throat
Active, not recruitingObservational study
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Spinal Cord Injury, Spinal Cord Injury at C5-C7 Level
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Zheng Xie, MD, PhD principal investigator
University of Chicago
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sedline Brain Function Monitor in people with Surgery, run by University of Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 12 Aug 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Speed of Recovery Time (time frame: Up to 3 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.